117-s-164117th CongressWALLET

Advancing Education on Biosimilars Act of 2021

Sponsored By: Senator Hassan, Margaret Wood [D-NH]

Became Law

Summary

Education on biosimilars to help clinicians, patients, and caregivers understand biosimilar and interchangeable biological drugs. It creates an online education program and continuing education for health care providers, and it requires publication of regulators' action packages or summary reviews while protecting trade secrets.

Show full summary
  • Health care providers get continuing education, webinars, and clinical materials about development pathways, review standards, prescribing considerations, comparability, and how to report adverse events.
  • Patients and caregivers get an online hub with videos, fact sheets, infographics, and toolkits that explain terms like “biosimilar” and “interchangeable” and how to report problems.
  • Product sponsors and the public gain continued access to each biological product’s action package or summary review, with explicit protection for trade secrets and confidential commercial information.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

More education and transparency on biosimilars

The law advances education on biologic drugs, especially biosimilars. The Secretary may run a website and offer continuing education for doctors, plus materials for patients and caregivers. Topics include what “biosimilar” and “interchangeable” mean, FDA review and licensing standards, and how to report side effects. The Secretary also publishes either the action package or a summary review for each licensed biologic. Trade secrets and confidential business information stay protected. This starts upon enactment.

Sponsors & CoSponsors

Sponsor

Hassan, Margaret Wood [D-NH]

NH • D

Cosponsors

  • Sen. Cassidy, Bill [R-LA]

    LA • R

    Sponsored 2/2/2021

Roll Call Votes

All Roll Calls

Yes: 412 • No: 8

house vote • 4/14/2021

On Motion to Suspend the Rules and Pass

Yes: 412 • No: 8

View on Congress.gov
Back to Legislation